Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data

por Isaac, Krista, Mato, Anthony R
Publicado 2020

Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia

por Rhodes, Joanna M, Mato, Anthony R
Publicado 2021

Novel-agent combination therapies in chronic lymphocytic leukemia: the law of relative contributions

por Mato, Anthony R., Roeker, Lindsey E.
Publicado 2022

All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia

por Thompson, Meghan C., Roeker, Lindsey E., Mato, Anthony R.
Publicado 2021

Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunother...

por Emond, Bruno, Sundaram, Murali, Romdhani, Hela, Lefebvre, Patrick, Wang, Song, Mato, Anthony
Publicado 2019

The potential of pirtobrutinib in multiple B-cell malignancies

por Jensen, Jeffrey L., Mato, Anthony R., Pena, Camila, Roeker, Lindsey E., Coombs, Catherine C.
Publicado 2022

Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia

por Roeker, Lindsey E., Sarraf Yazdy, Maryam, Rhodes, Joanna, Goodfriend, Julie, Narkhede, Mayur, Carver, Joseph, Mato, Anthony
Publicado 2019

COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia

por Shadman, Mazyar, Liu, Catherine, Eakle, Katherine, Hiew, Hwai J., Biondo, Juliana M.L., Ghia, Paolo, Mato, Anthony R.
Publicado 2022

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib

por Mato, Anthony R., Tang, Boxiong, Azmi, Soraya, Yang, Keri, Zhang, Xiaojuan, Stern, Jennifer C., Hedrick, Eric, Huang, Jane, Sharman, Jeff P.
Publicado 2022

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

por Roeker, Lindsey E., Knorr, David A., Pessin, Melissa S., Ramanathan, Lakshmi V., Thompson, Meghan C., Leslie, Lori A., Zelenetz, Andrew D., Mato, Anthony R.
Publicado 2020

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

por Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
Publicado 2020

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia

por Roeker, Lindsey E., DerSarkissian, Maral, Ryan, Kellie, Chen, Yan, Duh, Mei Sheng, Wahlstrom, Svea K., Hakre, Shweta, Yu, Louise, Guo, Helen, Mato, Anthony R.
Publicado 2023

Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry

por Mato, Anthony R., Ghosh, Nilanjan, Sharman, Jeff P., Brander, Danielle, Gutierrez, Meghan, Huang, Qing, Wu, Linda H., Young, Alex, Upasani, Sandhya, Naganuma, Maoko, Barrientos, Jacqueline C.
Publicado 2022

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

por Nagle, Sarah J, Shah, Nirav N, Ganetsky, Alex, Landsburg, Daniel J, Nasta, Sunita D, Mato, Anthony, Schuster, Stephen J, Reshef, Ran, Tsai, Donald E, Svoboda, Jakub
Publicado 2017

The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase...

por Mato, Anthony R., Sharman, Jeff P., Biondo, Juliana M.L., Wu, Mei, Mun, Yong, Kim, Su Y., Humphrey, Kathryn, Boyer, Michelle, Zhu, Qian, Seymour, John F.
Publicado 2020

A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (C...

por Mato, Anthony, Tang, Boxiong, Azmi, Soraya, Yang, Keri, Han, Yi, Zhang, Xiaowei, Roeker, Lindsey, Wallis, Nicola, Stern, Jennifer C., Hedrick, Eric, Huang, Jane, Sharman, Jeff P.
Publicado 2023

COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study

por Ip, Andrew, Mato, Anthony, Intrator, Jordan, Howard, Nicholas P, Petrillo, Alessandra, Vicioso, Rosalba, Sebti, Rani, Cicogna, Cristina, Magarelli, Gabriella, Leslie, Lori A., Goy, Andre H., Feldman, Tatyana A.
Publicado 2020

P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STU...

por Cohen, Jonathon, Roeker, Lindsey, Cheah, Chan, Eyre, Toby, Patel, Krish, Woyach, Jennifer, Seymour, John, Wang, Michael, Wang, Yucai, Loubert, Angely, Payakachat, Nalin, Hess, Lisa, Abada, Paolo, Mato, Anthony R., Ghia, Paolo
Publicado 2023

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

por Nabhan, Chadi, Mato, Anthony, Flowers, Christopher R., Grinblatt, David L., Lamanna, Nicole, Weiss, Mark A., Davids, Matthew S., Swern, Arlene S., Bhushan, Shriya, Sullivan, Kristen, Flick, E. Dawn, Kiselev, Pavel, Sharman, Jeff P.
Publicado 2017

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect(®) CLL Registry

por Sharman, Jeff P., Cocks, Kim, Nabhan, Chadi, Lamanna, Nicole, Kay, Neil E., Grinblatt, David L., Flowers, Christopher R., Davids, Matthew S., Kiselev, Pavel, Swern, Arlene S., Sullivan, Kristen, Gharibo, Mecide M., Flick, E. Dawn, Trigg, Andrew, Mato, Anthony
Publicado 2020